AI Buyer Insights:

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

GenomeDx Biosciences Tech Stack and Enterprise Applications

GenomeDx Biosciences ERP
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Oracle Legacy Oracle NetSuite ERP ERP Financial ERP n/a 2015 2015
In 2015, GenomeDx Biosciences implemented Oracle NetSuite ERP as its ERP Financial solution for core finance and accounting functions. The 70-employee United States consumer packaged goods company configured Oracle NetSuite ERP to centralize transaction recording and reporting across its finance organization. Deployment used a cloud SaaS instance of Oracle NetSuite ERP provisioned with core financial modules including general ledger, accounts payable, accounts receivable, cash management, fixed assets, and financial reporting. The implementation emphasized chart of accounts rationalization, role based access control, audit trail enabled transaction posting, and month end close workflows to standardize accounting processes across the finance and accounting departments.
GenomeDx Biosciences Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2015 2015
In 2015 GenomeDx Biosciences implemented Microsoft 365 as its Collaboration platform to centralize email, document collaboration, and real time team communication across the organization. The deployment is presented on the company website and reflects a cloud hosted Microsoft 365 tenant with centralized administration and identity controls scaled for a 70 person company, providing the core Collaboration services used across the business. The Microsoft 365 implementation includes standard Collaboration modules such as Exchange Online for corporate email, SharePoint Online for intranet and shared document libraries, OneDrive for Business for user file sync, and Microsoft Teams for persistent chat and meetings. Operational coverage spans product development, marketing, sales, and administrative functions, with governance implemented through centralized user provisioning, admin role separation, and baseline compliance and retention settings to manage document lifecycle and access control.
GenomeDx Biosciences Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Exclaimer Legacy Exclaimer Cloud Signatures for Office 365 Digital Signing Content Management n/a 2017 2017
In 2017, GenomeDx Biosciences implemented Exclaimer Cloud Signatures for Office 365. GenomeDx deployed Exclaimer Cloud Signatures for Office 365 as a Digital Signing solution to centralize corporate email signature management and enforce consistent branded outbound messaging across its Office 365 tenant, with the implementation visible in the public site source. The cloud-hosted Exclaimer implementation integrates directly with Office 365 mail flow and user accounts to apply centrally managed signature templates, aligning marketing and customer-facing functions under a single brand standard. Administration and policy control are handled at the tenant level to provide organization-wide signature governance for a company of approximately 70 employees, using Exclaimer Cloud Signatures for Office 365 to connect Digital Signing capabilities to email and branding workflows.
GenomeDx Biosciences CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Marketing Automation CRM 2017 2017
Marketing Automation CRM 2017 2017
Sales Automation, CRM, Sales Engagement CRM 2021 2021
GenomeDx Biosciences IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2013 2013
Application Hosting and Computing Services IaaS 2021 2021

IT Decision Makers and Key Stakeholders at GenomeDx Biosciences

First Name Last Name Title Function Department Email Phone
Chief Operating Officer CXO Finance
President & CSO, Director Director Finance
VP of Sales and Support VP Sales

Apps Being Evaluated by GenomeDx Biosciences Executives

APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from GenomeDx Biosciences IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the GenomeDx Biosciences digital transformation priorities and AI adoption trends.
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD GenomeDx Biosciences Technographics
GenomeDx Biosciences is a Consumer Packaged Goods organization based in United States, with around 70 employees and annual revenues of $7.0 million.
GenomeDx Biosciences operates a diverse technology stack with applications such as Oracle NetSuite ERP, Microsoft 365 and Exclaimer Cloud Signatures for Office 365, covering areas like ERP Financial, Collaboration and Digital Signing.
GenomeDx Biosciences has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Oracle, Microsoft and Exclaimer.
GenomeDx Biosciences recently adopted applications including Salesforce Sales Cloud in 2021, Google Cloud Platform (GCP) in 2021 and Exclaimer Cloud Signatures for Office 365 in 2017, highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of GenomeDx Biosciences’s key decision makers and IT executives, available to Premium subscribers.
Our research team continuously updates GenomeDx Biosciences’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete GenomeDx Biosciences technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.